Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001808296-26-000004

Director sold 2,625 shares at $10.73 ($28,166)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farzan Nima Director 2026-06-04 Sale 10b5-1 −2,625 $10.73 $28,166 9,767 D: show line 1 in the form
Open-market sales · 2,625 sh · avg $10.73 · $28,166
Loading xslF345X06/form4-06082026_080648.xml…